It has been bring to the table a novel genomic tool that would help to predict which patients will respond poorly to conventional treatments and, therefore, would be early candidates for treatment wit...
Read moreAn international study led by I3PT notes that clinical trials may account for only about one-fifth of people in the real world with schizophrenia spectrum disorders, and points out that new studies sh...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...
Read moreGoal is to characterize the neuropsychiatric symptoms of patients harboring disease-causing SETD1A gene mutations Also includes fundamental research in preclinical SETD1A models
Read moreSchizophrenia is a severe neuropsychiatric disorder which is presented through hallucinations, delusions and behavioural and motor disorders. Historically, this disease was associated with an overacti...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...
Read moreAn international collaboration, which included the involvement of the research team from the Institut de Neurociències (INC) and from the Department of Cellular Biology, Physiology and Immunology, ha...
Read moreWithin the framework of the X Esteve Foundation Discussion Group, on February 13th and 14th the tenth meeting of the working group on new advances in the field of G-protein coupled receptors (GPCR) wa...
Read moreSchizophrenia is a very heterogeneous disease, patients who suffer this may present a variety of symptoms. In addition, there is currently no analytical or imaging test that confirms the diagnosis. Th...
Read moreThe UPV/EHU-University of the Basque Country is proposing improvements with respect to the pharmacological study of cognitive function enhancers in patients with schizophrenia
Read morePara intentar clarificar el tipo de anomalías estructurales cerebrales presentes en la esquizofrenia, se ha llevado a cabo un innovador meta-análisis prospectivo que analiza datos de imagen cerebral...
Read more